Study	Reason for exclusion
Argyroudis 1997	Not clear whether randomised or not; impossible to contact study author to ask for details on methods
Baksu 2005	Inclusion not apparently limited to women who were experiencing vasomotor symptoms at baseline. No other outcomes of interest measured
Beardsworth 1999	Study vs no treatment
Berlanga 2003	Inclusion not apparently limited to women who were experiencing vasomotor symptoms at baseline. No other outcomes of interest measured
Bhattacharya 2008	Results on somatovegetative and urogenital symptoms assessed through score but specific outcomes of interest to this review not measured
Bhattacharya 2010	Results on somatovegetative and urogenital symptoms assessed through score but specific outcomes of interest to this review not measured
Bukulmez 2001	Measured no outcomes of interest
Cagnacci 2004	Measured no outcomes of interest
Cayan 2008	No available data explicitly comparing tibolone vs combined hormone therapy
De Censi 2013	Participants not randomised to tibolone
Fedele 2000	No outcomes of interest measured
Gambacciani 2004	Study vs no treatment
Genazzani 2011	Wrote to study authors to ask for data but received no response
Inan 2005	No outcomes of interest measured
Lundstrom 2011	Ineligible outcomes (breast density)
Nappi 2006b	Sexual dysfunction as vaginal health index (not provided for in the protocol)
Onalan 2005	No outcomes of interest measured
Palacios 1995	Compared tibolone vs calcium tablets
Silva 2015	Conference proceeding with no data on outcomes of interest
Simsek 2002	Measured no outcomes of interest
Stefanos 2010	Included participants with regular menstruation
Stevenson 2011	Not an RCT; review with unretrievable full text
Tasic 2011	Measured no outcomes of interest
Yuk 2012	Ineligible outcomes (changes in body composition and body size), unretrievable full text